Nebulizers Market - Global Industry Insights and Forecast till 2025Posted by Pareesh on October 30th, 2017 Nebulizersare drug delivery devices that are used to administer medicines inthe form of a mist inhaled into the lungs. This drug delivery methodhelps in the administration of drugs such as corticosteroids,bronchodilators and anti-inflammatory medications. Nebulizers aremainly used for patients suffering from asthma, cystic fibrosis,chronic obstructive pulmonary disease (COPD) and other respiratorydiseases or disorders. It is much comfortable to use than other formsof ingested medicines, as it targets the respiratory area directly,thus reducing side effects and harm to other body organs and cells.Nebulizers are especially used for delivery of drug to breathingpassages, reduce bulging of mucous membrane, to reduce irritationcaused by pollutants and activate and thin out discharge. Thesedevices are specially developed for adults and children who are notable to handle inhalers. Get atrending sample of this report :https://www.coherentmarketinsights.com/insight/request-sample/545 The use ofnebulizer depends on the illness for which it is designed to treat.Various considerations to be taken care of while using a nebulizerare as follows:
NebulizersMarket taxonomy: Onthe basis of product type, the nebulizers market is classified into:
Ultrasonicnebulizers include portable and standalone nebulizers. Pneumaticnebulizers are further classified into:
Also, meshnebulizers are also further classified into:
Pneumaticnebulizers hold the major share in nebulizers market due to theirease of handling, efficient design and low cost. Onthe basis of end user, the nebulizers market is classified into:
Productinnovation driving the preference for nebulizers in treatingrespiratory conditions Theadvanced nebulizers that features aerosol drug delivery technologywith minimal drug wastage is expected to drive the nebulizers marketgrowth. Patients play a vigorous role in supervising their diseasesby choosing for devices that assist them in diagnosis and treatmentat the comfort of their own homes. This shift in patient preferenceswill strengthen the global nebulizer market growth scenario in thenear future. Also the rise in respiratory cases form a major factor.According to World Health Organization (WHO), around 15.7 millionpeople were reported with Chronic Obstructive Pulmonary Disease(COPD) in the U.S. in 2016 which showed a significant increase of6.4% from 2015. Nebulizersare also for a variety of diagnostic procedures among which theprincipal one is in diagnosis of lung function and bronchialactivities. This has also added to the rise in demand for nebulizersin the market by the professionals for clinical use and monitoring ofvarious associated respiratory disorders. Medicalreimbursement supporting the North America nebulizer market growth There areguidelines laid for nebulizers which facilitates its proper usage.The Centers for Medicare & Medicaid Services, and UnitedHealthCare Services, Inc. have defined guidelines for the properusage of nebulizers in different respiratory issues. In addition tothat there are various reimbursement policies that fuel the growth ofthe market, for instance, policies by Medicaid & HealthcarePartnership in 2012 helped in the easy purchase of nebulizers. UnderHawaii Medical Service Association, in 2014, several cover plans weremade for the easy purchases of small volume and large volumenebulizers. Also, thereexists a rental market for nebulizers that assists the usage of thesedevices in home care settings. Sincenebulization is a spraying technique, therefore the dispersion andwastage of the drug during delivery to the respiratory tract is oneof the major restraint for the growth of nebulizers market. Moreover,low consumer switching cost and availability of alternative therapiesincreases the threat of substitute products. Bygeography, North America holds the major share in the globalnebulizers market because of the availability of reimbursement andincreasing incidence of respiratory diseases. Key playersin the global nebulizers market are GE Healthcare Ltd, AgilentTechnologies, GF Health Products, Philips Healthcare CareFusionCorporation, PARI Respiratory Equipment, Covidien plc and OmronHealthcare Co. The players are undertaking various clinical trialsand development activities in an endeavor to improve therapeuticeffect of the drug. Theravance Biopharma and Mylan announced theinitiation of phase 3 studies of revefenacin at the American ThoracicSociety (ATS) International Conference in 2017. Revefenacin is aonce-daily long acting muscarinic antagonist (LAMA) nebulizedtherapy. Development of such drugs intended to be delivered vianebulization will also support propelling the growth for nebulizersmarket. Also Vectura received FDA approval to start testing a smarttechnology of nebulizers to improve asthma therapies in children. AboutCoherent Market Insights: CoherentMarket Insights is a prominent market research and consulting firmoffering action-ready syndicated research reports, custom marketanalysis, consulting services, and competitive analysis throughvarious recommendations related to emerging market trends,technologies, and potential absolute dollar opportunity ContactUs: Mr.Shah CoherentMarket Insights Tel:+1–206–701–6702 Like it? Share it! More by this author |